The Zodiak Trial: Protocol of a Double-Blind, Placebo-Controled, Two-Year Clinical Trial of Zoledronic Acid as a Disease-Modifying Drug in Knee Osteoarthritis With Bone Marrow Lesions
Osteoarthritis and Cartilage - United Kingdom
doi 10.1016/j.joca.2019.02.563
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2019
Authors
Publisher
Elsevier BV